Library

| Daily Briefing

Mixing grapefruit with these 85 medications can be harmful—even deadly


A new study identifies as many as 85 common medications that interact with grapefruit, and at least 43 such interactions can have serious side effects—including sudden death, kidney failure, and internal bleeding.

Writing in the Canadian Medical Association Journal, Lawson Health Research Institute's David Bailey—who first discovered that the bitter fruit can interact with drugs more than 20 years ago—and colleagues reported that the number of drugs that can interact harmfully with grapefruit has increased from 17 to 43 in the last four years.

The chemical culprits in grapefruits are called furanocoumarins, which deactivate an enzyme found in the small intestine and liver that breaks down various toxins and an estimated 50% of all drugs. When the enzyme doesn't function normally, medications may not degrade and instead circulate in the blood at higher levels than normal. This can effectively cause a medication overdose.

"Taking one tablet with a glass of grapefruit juice is like taking five tablets with water," Bailey says.

Popular drugs that interact negatively with grapefruit include various antibiotics, as well as drugs that treat hypertension, high cholesterol, and cancer.

The study notes that grapefruits are not the only fruits to cause problems with medications: Seville oranges, pomelos, and limes also contain the same family of disruptive compounds.

The study authors urge physicians to learn more about drug interactions with grapefruit (Thompson, "Shots," NPR, 11/27; United Press International, 11/27; Brown, "Booster Shots," Los Angeles Times, 11/27).


SPONSORED BY

INTENDED AUDIENCE

AFTER YOU READ THIS

AUTHORS

TOPICS

Don't miss out on the latest Advisory Board insights

Create your free account to access 1 resource, including the latest research and webinars.

Want access without creating an account?

   

You have 1 free members-only resource remaining this month.

1 free members-only resources remaining

1 free members-only resources remaining

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
AB
Thank you! Your updates have been made successfully.
Oh no! There was a problem with your request.
Error in form submission. Please try again.